Alzheimer’s Disease

Alzheimer’s Disease

Phase II study of lecanemab in early AD 1:31
Phase II study of lecanemab in early AD
Chad Swanson • 26 Apr 2021
Open-label extension study of lecanemab in early Alzheimer’s disease 4:57
Open-label extension study of lecanemab in early Alzheimer’s disease
Chad Swanson • 26 Apr 2021
What does a healthy brain look like when it’s sleeping in relation to optimal cognitive performance? 4:07
What does a healthy brain look like when it’s sleeping in relation to optimal cognitive performance?
Logan Schneider • 7 Apr 2021
Highlights from AD/PD: Donanemab & iADRS 3:45
Highlights from AD/PD: Donanemab & iADRS
Suzanne Hendrix • 17 Mar 2021
Important considerations for APOE disclosure in AD risk assessment 3:00
Important considerations for APOE disclosure in AD risk assessment
Stephen Salloway • 10 Mar 2021
Gamma sensory stimulation for the treatment of AD 3:35
Gamma sensory stimulation for the treatment of AD
Li-Huei Tsai • 19 Mar 2021
Highlights from AD/PD: advances in AD research 2:50
Highlights from AD/PD: advances in AD research
Silvia Fossati • 16 Mar 2021
Barriers to major advances in the Alzheimer’s field 1:39
Barriers to major advances in the Alzheimer’s field
Stephen Salloway • 10 Mar 2021
The olfactory mucosa as a potential in vitro model for AD 2:17
The olfactory mucosa as a potential in vitro model for AD
Riikka Lampinen • 17 Mar 2021
Gamma frequency neuromodulation in AD: results from the Overture study 3:39
Gamma frequency neuromodulation in AD: results from the Overture study
Suzanne Hendrix • 17 Mar 2021
Is there an association between AD and COVID-19? 2:02
Is there an association between AD and COVID-19?
Katja Kanninen • 17 Mar 2021
Microvascular endothelial cell dysfunction in AD & CAA 6:29
Microvascular endothelial cell dysfunction in AD & CAA
Silvia Fossati • 16 Mar 2021
A post-hoc analysis of LipidiDiet: ADCOMS, GST & BHA 4:23
A post-hoc analysis of LipidiDiet: ADCOMS, GST & BHA
Suzanne Hendrix • 17 Mar 2021
Progress in Alzheimer’s disease: aducanumab, imaging, and blood biomarkers 2:53
Progress in Alzheimer’s disease: aducanumab, imaging, and blood biomarkers
Stephen Salloway • 10 Mar 2021
Online registries allow rapid recruitment of diverse populations for AD trials 1:46
Online registries allow rapid recruitment of diverse populations for AD trials
Stephen Salloway • 10 Mar 2021
The influence of the gut microbiome on amyloid-beta 5:44
The influence of the gut microbiome on amyloid-beta
Sangram Sisodia • 16 Mar 2021
The content of VJNeurology is intended for healthcare professionals